Purdue Pharma's Chapter 11 plan shielded the Sackler family from opioid claims. The Supreme Court struck down those non-consensual releases in June 2024, forcing a renegotiated settlement.
Searching the public web for this case…
Loading priority…

Purdue files for bankruptcy amid thousands of opioid suits.
Plan confirmation is reversed, revived and appealed.
The Supreme Court holds the Bankruptcy Code does not authorise the Sackler releases.
A revised plan with roughly $7.4bn in payments advances.